Company Description
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.
It operates through three segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation.
The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.
Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer.
The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services.
Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
| Country | United States |
| Founded | 1996 |
| IPO Date | Sep 25, 2009 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 44,100 |
| CEO | David Chernow |
Contact Details
Address: 4714 Gettysburg Road, P.O. Box 2034 Mechanicsburg, Pennsylvania 17055 United States | |
| Phone | 717 972 1100 |
| Website | selectmedical.com |
Stock Details
| Ticker Symbol | SEM |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001320414 |
| CUSIP Number | 81619Q105 |
| ISIN Number | US81619Q1058 |
| SIC Code | 8060 |
Key Executives
| Name | Position |
|---|---|
| David S. Chernow | Director and Chief Executive Officer |
| Robert A. Ortenzio | Co-Founder and Executive Chairman |
| Thomas P. Mullin | Co-President |
| Michael F. Malatesta | Executive Vice President and Chief Financial Officer |
| Martin F. Jackson | Senior Executive Vice President of Strategic Finance and Operations |
| John A. Saich | Co-President |
| Christopher S. Weigl | Senior Vice President, Controller and Chief Accounting Officer |
| Brian R. Rusignuolo | Executive Vice President and Chief Information Officer |
| Michael E. Tarvin | Senior Executive Vice President, General Counsel and Secretary |
| Robert G. Breighner Jr. | Senior Vice President of Compliance and Audit |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 11, 2025 | DEFR14A | Filing |
| Mar 5, 2025 | ARS | Filing |
| Mar 5, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 5, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 21, 2025 | PRE 14A | Other preliminary proxy statements |
| Feb 20, 2025 | 10-K | Annual Report |
| Feb 20, 2025 | 8-K | Current Report |
| Feb 5, 2025 | SCHEDULE 13G/A | Filing |
| Jan 30, 2025 | SCHEDULE 13G/A | Filing |
| Dec 4, 2024 | 8-K | Current Report |